Blockchain in Genomics Market Size, Share, By Component (Software and Platforms), Business Model (B2B Business Model, B2C Business Model, and C2B Business Model), Deployment Model (On-premise and Cloud-based), Application (Secure Data Sharing, Patient Consent Management, Data Provenance and Integrity, Genomic Data Repositories, Enhanced Data Analytics, and Others), End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Hospitals and Clinics, Government Agencies, and Others), and Region - Trends, Analysis, and Forecast till 2035

• By 2035, the blockchain in genomics market size is expected to grow at a rate of USD 4455.9 Million.
• The market was worth USD 37 Million in 2024.
• Target market is growing at a CAGR of 59.7%.

Blockchain in genomics refers to the use of blockchain technology to manage and secure genetic data. Blockchain can create decentralized platforms where individuals can sell or share its genomic data, providing it with greater control and potential financial benefits, and driving blockchain in genomics market growth. In addition to this, the blockchain in genomics maintains data integrity and immutability, helps in data provenance and traceability, enhances privacy controls, facilitates data sharing, it is transparent and auditable, and the increasing popularity of blockchain technology in healthcare and the need for secure and traceable genomic data, thus, helping in further market augmentation.

Impact of AI on Blockchain in Genomics Market:

AI greatly expands the potential of blockchain technology in the blockchain in genomics market by making it possible to analyze large amounts of genomic data securely and effectively, enabling personalized medicine, speeding up drug discovery, and improving data integrity through tamper-proof record-keeping on the blockchain, all of which improve patient care and research results.

Key Drivers of Target Market:

Capability of Blockchain in Genomics to Enhance Data Analysis and Integrity is contributing to the Market Expansion

Blockchain technology has the potential to greatly improve data analysis and integrity in the field of genomics by offering a safe, transparent, and unchangeable ledger for managing and storing genetic data. This will enable researchers and healthcare professionals to track the provenance of data, confirm its authenticity, and protect privacy throughout the entire analysis process, which will ultimately result in more dependable and trustworthy genomic research and clinical applications.

• For instance, in April 2024, Coral Health leveraged blockchain to integrate genomic and clinical data, enabling researchers to derive actionable insights for personalized medicine and targeted interventions. By analyzing diverse datasets on a decentralized platform, companies such as Coral Health could help accelerate drug discovery, individualize clinical protocols and produce improved patient outcomes.

Restraints:

High Energy Consumption of Blockchain Technology in Genomics is Hindering the Market Growth

The "proof-of-work" consensus mechanism, which is used in many blockchain networks and requires a lot of processing power to validate transactions, is the main cause of blockchain technology's high energy consumption, which can be an environmental concern even though it has great potential in the field of genomics for securely managing and sharing sensitive genetic data.

• Counterbalance Statements: Switch to energy-efficient consensus techniques, such as Proof-of-Stake (PoS) or Delegated Proof-of-Stake (DPoS) can help in lowering blockchain's energy consumption in genomics.

Opportunities:

Improved Patient-Centric Models of Blockchain in Genomics is Expected to Surge the Market Growth

Blockchain has the potential to transform how genomic data is managed, ensuring ethical practices and driving innovation in healthcare due to the evolution of regulatory frameworks and technologies. Blockchain could empower patients by giving it greater control over its genomic data, leading to more personalized healthcare solutions tailored to individual genetic profiles.

• For instance, in October 2021, In order to create a patient-centric approach for clinical trials and research, DNAnexus and Medable worked together to incorporate blockchain technology into its genomic data systems. Through this collaboration, patients safely provided researchers access to their genetic data while keeping control and ownership. By guaranteeing data integrity, transparency, and privacy, the blockchain-based system promoted confidence and speed up the development of tailored treatment.

Component, business model, deployment model, application, end-user, and region are the segmentations of this market.

Component

On the foundation of component, the market is catalogued into software, and platforms. The software segment is expected to govern the market as there is a rising demand for blockchain-based software solutions to improve the effectiveness and security of handling and interpreting genetic data.

• For instance, in April 2024, BioAro, a pioneer in genomic research and technology, was set to officially launch PanOmiQ, a revolutionary blockchain in genomics software that would redefine the landscape of genomic analysis globally by providing real-time insights into the complexities of the human genome. With unparalleled speed, precision, and versatility, it promised to transform healthcare worldwide.

Business Model

The market is divided into B2B business model, B2C business model, and C2B business model, on the groundwork of business model. The B2B (Business-to-Business) business model is forecasted to rule over the market due to the widespread adoption of blockchain technology in complex business operations such as supply chain management across various industries, including finance, healthcare, and manufacturing. Thereby, it is more relevant to large enterprises than direct consumer applications.

Deployment Model

Dependent on deployment model, the market is bifurcated into on-premises and cloud-based. The cloud-based deployment model holds the largest blockchain in genomics market share due to its scalability, cost-efficiency, and flexibility.

• For instance, in May 2024, SOPHiA GENETICS, a cloud-native healthcare technology company with cloud-based deployment model, and a global leader in data-driven medicine, announced its collaboration with Microsoft and NVIDIA to leverage its expertise in technology and genomics to bring a streamlined and scalable whole genome sequencing (WGS) analytical solution to healthcare institutions, with the aim to make the solution available to customers.

Application

Hinging on application, the market is sub-segmented into secure data sharing, patient consent management, data provenance and integrity, genomic data repositories, enhanced data analytics, and others. The secure data sharing segment is influencing the market as decentralized and tamper-proof nature of blockchain technology perfectly addresses the critical need for secured and controlled sharing of sensitive genomic data between researchers, healthcare providers, and pharmaceutical companies.

End-User

By end-user, the market is classified into pharmaceutical and biotechnology companies, academic and research institutions, hospitals and clinics, government agencies, and others. The pharmaceutical and biotechnology companies is attributed to dominate the market due to the growing need for customized treatment and the expanding use of blockchain technology for safe data storage and sharing.

• For instance, in July 2024, Genomics plc, a healthcare company transforming health through the power of genomics announced a three-year extension of the company's collaboration with Vertex Pharmaceuticals Incorporated to use human genetics with the help of blockchain technology and machine learning to improve the discovery and development of new precision medicines. The companies had been working together to support Vertex's efforts to develop transformative medicines for serious diseases.

Region

Regionally, the market is grouped into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America: North America has the biggest blockchain in genomics market share due to factors, such as the region’s strong financial services sector, the popularity of digital payment systems, and the growing acceptance of crypto currencies. This region also has an early adoption of blockchain technology in industries including finance, healthcare, and supply, thereby, further diversifying the market.

• For instance, in May 2024, Complete Genomics, a pioneering genomic sequencing company, expanded its U.S. manufacturing footprint with blockchain technology capabilities to diversify its supply chain helping it to continue reliably serving customers with flexible, cost-effective next generation sequencing (NGS) solutions for diseases such as Alzheimer’s, obesity, cancer, and others.

Europe: This region has the fastest growing CAGR in the market. This is due to strong existing genomics research infrastructure, a focus on data privacy regulation, such as GDPR, a supportive regulatory environment for innovation, high adoption of advanced sequencing technologies, and a large number of healthcare providers and pharmaceutical companies that explore blockchain applications in the field of genomics.

For instance, in June 2022, The Russian non-profit GenoBank.io. launched the beta release of the first decentralized ‘genomic internet’, which was expected to make possible the safe storage of large amounts of genetic data. Using a decentralized network similar to blockchain, GenoBank.io’s newly launched ‘genomic internet’ aimed to deal with the challenges of storage, privacy, and sharing data in joint research projects.

Blockchain in Genomics Market Report Scope:

Attribute	Details
Market Size 2025	USD 62.7 Million
Projected Market Size 2035	USD 4455.9 Million
CAGR Growth Rate	59.7% (2025-2035)
Base year for estimation	2024
Forecast period	2025 – 2035
Market representation	Revenue in USD Million & CAGR from 2025 to 2035
Regional scope	North America - U.S. and Canada Europe – Germany, U.K., France, Russia, Italy, Spain, Netherlands, and Rest of Europe Asia Pacific – China, India, Japan, Australia, Indonesia Malaysia, South Korea, and Rest of Asia Pacific Latin America - Brazil, Mexico, Argentina, and Rest of Latin America Middle East & Africa – GCC, Israel, South Africa, and Rest of the Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segmentation:

By Component:

• Software
  • Nebula Genomics
  • DNAtix
  • Genomic Beacon Project
• Platforms
  • Ethereum
  • Hyperledger Fabric
  • Quorum

By Business Model:

• B2B Business Model
• B2C Business Model
• C2B Business Model

By Deployment Model:

• On-premises
• Cloud-based

By Application:

• Secure Data Sharing
• Patient Consent Management
• Data Provenance and Integrity
• Genomic Data Repositories
• Enhanced Data Analytics
• Others

By End User

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutions
• Hospitals and Clinics
• Government Agencies
• Others

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of the Middle East & Africa

The companies operating in the market are Nebula Genomics, Inc., GenoBank.io, Lifebit Biotech Ltd, Stellarix.com, and others. The key players are adopting strategies such as focusing on secure, transparent, and decentralized system for storing and sensitive genetic data, and enabling improved data sharing between research and healthcare providers for the diversification of the market.

List of Key Players in the Market:

• Nebula Genomics, Inc.
• GenoBank.io
• Lifebit Biotech Ltd
• Stellarix.com
• QIAGEN
• Zenome
• Oasis Labs
• DNAtix
• EncrypGen
• GenomicDAO

• In June 2024, GenomesDAO, a pioneering biotech company focused on the secure, private, and auditable monetization of genomic data, announced the successful completion of a new collaboration with Pantera Capital and Modular Capital, whose expertise in scaling blockchain companies was invaluable, thereby helping in advancing the genomics market with the help of blockchain technology.
• In September 2020, Nebula Genomics integrated with Oasis Labs to give users first-of-its-kind control of its personal genomic data with the help of blockchain technology. From massive data breaches to sales of private data, users and companies were more concerned than ever with keeping personal health information private and secure.

Analyst View:

The market for blockchain in genomics is expected to increase as a result of the decentralized platforms that blockchain may establish for people to sell or exchange its genetic data, giving it more power and possibly financial gains. Furthermore, the blockchain in genomics preserves data immutability and integrity, aids in data provenance and traceability, improves privacy controls, makes data sharing easier, and is visible and auditable, all of which contribute to future market expansion.

More Related Reports

Blockchain for Cold Chain Logistics Market
Blockchain Market
Blockchain in Energy Market
Blockchain Gaming Market
Blockchain Assessment Market

Company Name	GenoBank.io
Headquarter	San Mateo, California, U.S.
CEO	Mr. Daniel Uribe
Employee Count (2024)	10 Employees